Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity.
Tsaousidou E, Chrzanowski J, Drané P, Lee GY, Bahour N, Wang ZB, Deng S, Cao Z, Huang K, He Y, Kaminski M, Michalek D, Güney E, Parmar K, Fendler W, Chowdhury D, Hotamisligil GS.
Cell Rep. 2024 Jun 25. 43(6):114337. PMID: 38861384